BCAX
Bicara Therapeutics Inc.
20.50$
-10.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +0.0% | +15.4% | +0.0% | +26.7% | +0.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +52.2% | +13.9% | +31.7% | +0.1% | +25.3% | +72.7% | -27.8% | -76.5% | +467.1% | +44.0% | -3.6% | – | |
| – | +20.6% | +6.9% | +17.0% | +21.9% | +41.8% | +10.4% | -3.2% | +6.7% | +5.6% | +56.7% | +11.3% | – | |
| – | +43.6% | +12.3% | +28.5% | +4.4% | +29.1% | +56.9% | -23.4% | +27.0% | +1.1% | +46.5% | -0.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -80.0% | -50.0% | – | – | -61.3% | -27.8% | -23.1% | +32.5% | -198.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.